◆ NeutralADMA
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against ADMA Biologics, Inc. (ADMA)
GlobeNewswire Inc.·
A securities class action lawsuit has been filed against ADMA Biologics, Inc. for the period between August 9, 2024 and March 25, 2026. The complaint alleges the company engaged in undisclosed related party transactions, used channel stuffing to inflate revenue, and lacked adequate internal controls. Following a critical report by Culper Research on March 24, 2026, ADMA stock fell 16.6% and an additional 15% the next day.
Read Full Article at GlobeNewswire Inc. →